Histopathology Department

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• Pfizer2 trials

Closed trials

• Completed

  Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

  NCT02007512· Phase 2· Pfizer· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

  NCT01889238· Phase 2· Pfizer· Source